REFERENCES
- Meissner HC. Viral Bronchiolitis in Children. N Eng J Med
2016;374:62-72.
- Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE,
Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, et al.
Clinical Practice Guideline: The Diagnosis, Management and Prevention
of Bronchiolitis. Pediatrics 2014;134(5):e1474–502.
- Brice DC, Diamond G. Antiviral activities of human host defense
peptides. Curr Med Chem
2020;27(9):1420–43.
- Ahmed
A, Siman-Tov G, Hall, G, Bhala N, Narayanan A. Human Antimicrobial
Peptides as Therapeutics for Viral Infections. Viruses 2019;
11(8):704.
- Elnagdy S, Alkhazindar M. The Potential of Antimicrobial Peptides as
an Antiviral against COVID-19. ΑCS Pharmacol Transl Sci
2020;3(4):780–782.
- Harcourt JL, McDonald M, Svoboda P, Pohl J, Tatti K, Haynes LM. Human
cathelicidin, LL-37, inhibits respiratory syncytial virus infection in
polarized airway epithelial cells. BMC Res Notes 2016;9:11.
- Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn KL.
Antiviral Activity of the Human Cathelicidin, LL-37, and Derived
Peptides on Seasonal and Pandemic Influenza A Viruses. PLoS ONE
2015;10(4):e0124706.
- Sousa FH, Casanova V, Findlay F, Stevens C, Svoboda P, Pohl J,
Proodfoot L, Barlow PG. Cathelicidins display conserved direct
antiviral activity towards rhinovirus. Peptides 2017;95:76–83.
- Currie SM, Findlay EG, McFarlane AJ, Fitch PM, Bottcher B, Colegrave
N, Paras A, Jozwik A, Chiu C, Schwarze J, et al. Cathelicidins have
direct antiviral activity against respiratory syncytial virus in vitro
and protective function in vivo in mice and humans. J Immunol
2016;196(6):2699-710.
- Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson
DJ, Donis RO. Antiviral activity and increased host defense against
influenza infection elicited by the human cathelicidin LL-37. PLoS
ONE 2011;6(10):e25333.
- Szymczak
I, Pawliczak R. The Active Metabolite of Vitamin D3 as a Potential
Immunomodulator.
Scand J Immunol
2016;83(2):83-91.
- Svensson D, Nebel D, Nilsson B. Vitamin D3 modulates the innate immune
response through regulation of the hCAP-18/LL-37 gene expression and
cytokine production. Inflamm Res 2016;65(1):25-32.
- Wang EE, Milner R, Allen U, Maj H. Bronchodilators for treatment of
mild bronchiolitis: a factorial randomised trial. Arch Dis
Child 1992;67:289–93.
- Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory
signs and oximetry in infants hospitalized with lower respiratory
infections. Am Rev Respir Dis 1992;145(1):106–9.
- Seng QB, Chin HJ. Reliability and Validity of Respiratory Score in the
Assement of Acute Bronchiolitis. Malays J Med Sci 2004;11(2):34-40.
- Mansbach JM, Piedra PA, Borregaard N, Martineau AR, Neuman MI,
Espinola JA, Camargo CA. Serum cathelicidin level is associated with
viral etiology and severity of bronchiolitis. J Allergy Clin Immunol
2012;130:1007-8.
- Mansbach JM, Hasegawa K, Ajami NJ, Petrosino JF, Piedra PA, Tierney
CN, Espinola JA, Camargo CA. Serum LL-37 level is associated with
severity of bronchiolitis and viral etiology. Clin Infect Dis
2017;65:967-75.
- Hasegawa K, Mansbach JM, Ajami NJ, Petrosino JF, Freishtat RJ, Teach
SJ, Piedra PA, Camargo CA. Serum cathelicidin, nasopharyngeal
microbiota, and disease severity among infants hospitalized with
bronchiolitis. J Allergy Clin Immunol 2017; 139:1383–6.
- Stukes TM, Shary JR, Wei W, Ebeling MD, Dezsi KB, Shary FS, Forestieri
NE, Hollis BW, Wagner CL. Circulating Cathelicidin Concentrations in a
Cohort of Healthy Children: Influence of Age, Body Composition, Gender
and Vitamin D Status. PLoS ONE 2016;11(5): e0152711.
- Davidopoulou S, Diza E, Menexes G, Kalfas S. Salivary concentration of
the antimicrobial peptide LL-37 in children. Arch Oral Biol
2012;57(7):865–9.
- Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho
PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D
are associated with impaired innate immune function. J Leukoc Biol
2012; 91(5):829-38.
- Ertugrul AS, Sahin H, Dikilitas A, Alpalsan NZ, Bozoglan A, Tekin Y.
Gingival crevicular fluid levels of human beta-defensin-2 and
cathelicidin in smoker and non-smoker patients: a cross-sectional
study. J Periodont Res 2014;49(3):282-9.
- Soldati KR, Toledo FE, Aquino SG, Rossa Jr C, Deng D, Zandim-Barcelos
DL. Smoking reduces cathelicidin LL37 and human neutrophil peptide 1-3
levels in the gingival crevicular fluid of patients with
periodontitis. J Periodont. 2020: doi.org/10.1002/JPER.20-0098.
- Havelka AM, Yektaei-Karin E, Hultenby K, Sorensen OE, Lundahl J,
Berggren V, Marchini G. Maternal plasma level of antimicrobial peptide
LL37 is a major determinant factor of neonatal plasma LL37 level. Acta
Paediatr 2010; 99(6):836–41.
- Gombart AF, O’Kelly J, Saito T, Koeffler HP. Regulation of the CAMP
gene by 1, 25(OH)2D3 in various
tissues. J Steroid Biochem Mol Biol 2007;103(3–5):552–7.
- Telcian
AG, Stanciu LA. Vitamin D increases the antiviral activity of
bronchial epithelial cells in vitro. Antiviral Res 2017;137:93-101.
- Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin SG, Ziegler TR,
Tangpricha V. Alterations in vitamin D status and anti-microbial
peptide levels in patients in the intensive care unit with sepsis. J
Transl Med 2009;7:28.
- Albanna EA, Ali YF, Elkashnia R AM. Vitamin D and LL-37 in children
with pneumonia. Egypt J Pediatr Allergy Immunol 2010;8(2):81–6.
- Georgieva V, Κamolvit W, Herthelius M, Luthje P, Brauner A, Chromek M.
Association between vitamin D, antimicrobial peptides and urinary
tract infection in infants and young children. Acta Paediatr
2019;108(3):551-6.
- Cakir E, Torun E, Gedik H, Umutoglu T, Actas EC, Topuz U, Deniz G.
Cathelicidin and human b-defensin 2 in bronchoalveolar lavage fluid of
children with pulmonary tuberculosis. Int J Tuberc Lung Dis 2014;
18(6):671-5.
- Beigelman
A,
Castro
M,
Schweiger
TL,
Wilson
BS,
Zheng
J,
Yin-DeClue
H, Sajol G, Giri T, Sierra OL, Isaacson-Schmid M, et al. Vitamin D
Levels Are Unrelated to the Severity of Respiratory Syncytial Virus
Bronchiolitis Among Hospitalized Infants. J Pediatric Infect Dis Soc
2015;4(3):182-8.
- Moreno-Solís G,
Fernández-Gutiérrez
F, Torres-Borrego
J, Torcello-Gáspar
R, Gómez-Chaparro
Moreno
JL, Pérez-Navero
JL. Low serum 25-hydroxyvitamin D levels and bronchiolitis severity
in Spanish infants. Eur J Pediatr 2015;174(3):365-72.
- Vo P, Koppel C, Espinola J, Mansbach J, Celedon J, Hasegawa K,
Bair-Merritt M, Camargo CA. Vitamin D status at the time of
hospitalization for bronchiolitis and its association with disease
severity. J Pediatr 2018;203:416-22.
- Wnorowska
U,
Fiedoruk
K,
Piktel
E, Prasad
SV,
Sulik
M,
Janion
M, , Daniluk T, Savage PB, Bucki R. Nanoantibiotics containing
membrane-active human cathelicidin LL-37 or synthetic ceragenins
attached to the surface of magnetic nanoparticles as novel and
innovative therapeutic tools: current status and potential future
applications, J Nanobiotechnology 2020;18(1):3.
- Wang
G, Narayana JL, Mishra B, Zhang Y, Wang F, Wang C, Zarena D,
Lushnikova T, Wang X. Design of Antimicrobial Peptides: Progress Made
with Human Cathelicidin LL-37. Adv Exp Med Biol 2019;1117:215-40.
- Kozhikhova KV, Shilovskiy IP, Shatilov AA, Timofeeva AV, Turetskiy EA,
Vishniakova LI, Nikolskij AA, Barvinskaya ED, Karthikeyan S, Smirnov
VV et al. Linear and dendrimeric antiviral peptides: design, chemical
synthesis and activity against human respiratory syncytial virus. J
Mater Chem B 2020;8(13):2607-17.